Stockreport

Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company deve [Read more]